Total Payments
$1,135
2024 Payments
$183.33
Companies
8
Transactions
17
Medicare Patients
1,612
Medicare Billing
$267,193
Payment Breakdown by Category
Food & Beverage$676.18 (59.6%)
Travel$261.64 (23.0%)
Education$197.34 (17.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $676.18 | 12 | 59.6% |
| Travel and Lodging | $261.64 | 1 | 23.0% |
| Education | $197.34 | 4 | 17.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AKEBIA THERAPEUTICS INC | $287.38 | 8 | $0 (2022) |
| Fresenius USA Marketing, Inc. | $261.64 | 1 | $0 (2019) |
| Aurinia Pharma U.S., Inc. | $150.00 | 1 | $0 (2023) |
| Relypsa, Inc. | $122.02 | 1 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $118.34 | 3 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $104.33 | 1 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $79.00 | 1 | $0 (2024) |
| Genentech USA, Inc. | $12.45 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $183.33 | 2 | AstraZeneca Pharmaceuticals LP ($104.33) |
| 2023 | $150.00 | 1 | Aurinia Pharma U.S., Inc. ($150.00) |
| 2022 | $141.74 | 2 | AKEBIA THERAPEUTICS INC ($141.74) |
| 2020 | $227.51 | 6 | Otsuka America Pharmaceutical, Inc. ($118.34) |
| 2019 | $420.13 | 5 | Fresenius USA Marketing, Inc. ($261.64) |
| 2017 | $12.45 | 1 | Genentech USA, Inc. ($12.45) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $79.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $104.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/02/2023 | Aurinia Pharma U.S., Inc. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 05/03/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $120.15 | General |
| Category: Nephrology | ||||||
| 01/19/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Nephrology | ||||||
| 08/31/2020 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: NEPHROLOGY | ||||||
| 07/01/2020 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: NEPHROLOGY | ||||||
| 03/04/2020 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | In-kind items and services | $72.79 | General |
| Category: NEPHROLOGY | ||||||
| 02/20/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Education | In-kind items and services | $95.51 | General |
| Category: NEPHROLOGY | ||||||
| 02/20/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Education | In-kind items and services | $12.48 | General |
| Category: NEPHROLOGY | ||||||
| 02/20/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Education | In-kind items and services | $10.35 | General |
| Category: NEPHROLOGY | ||||||
| 11/21/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $5.15 | General |
| Category: NEPHROLOGY | ||||||
| 11/08/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $12.28 | General |
| Category: NEPHROLOGY | ||||||
| 09/30/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.04 | General |
| Category: NEPHROLOGY | ||||||
| 05/10/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $122.02 | General |
| Category: Hyperkalemia | ||||||
| 01/18/2019 | Fresenius USA Marketing, Inc. | — | Travel and Lodging | Cash or cash equivalent | $261.64 | General |
| 02/08/2017 | Genentech USA, Inc. | GAZYVA (Biological) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 322 | 548 | $129,452 | $68,744 |
| 2021 | 7 | 549 | 941 | $160,146 | $96,534 |
| 2020 | 9 | 741 | 2,302 | $157,987 | $101,915 |
Total Patients
1,612
Total Services
3,791
Medicare Billing
$267,193
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 60 | 147 | $80,850 | $40,042 | 49.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 101 | 217 | $17,577 | $12,225 | 69.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 98 | $14,700 | $7,894 | 53.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 61 | 69 | $12,075 | $7,058 | 58.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $4,250 | $1,525 | 35.9% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 56 | 98 | $53,515 | $28,253 | 52.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 163 | 263 | $38,025 | $23,503 | 61.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 170 | 398 | $32,406 | $22,742 | 70.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 99 | 120 | $21,000 | $12,973 | 61.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 24 | 25 | $5,900 | $3,965 | 67.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $5,250 | $2,731 | 52.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 16 | $4,050 | $2,367 | 58.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 287 | 767 | $62,160 | $44,319 | 71.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 151 | 178 | $31,150 | $19,506 | 62.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 142 | 201 | $26,230 | $14,374 | 54.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 57 | 57 | $12,870 | $9,003 | 70.0% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2020 | 20 | 581 | $8,715 | $4,632 | 53.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 23 | 36 | $5,960 | $3,961 | 66.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 25 | 77 | $3,850 | $2,759 | 71.7% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2020 | 12 | 268 | $3,216 | $1,821 | 56.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 24 | 137 | $3,836 | $1,540 | 40.1% |
About Dr. Belen Nunez Cespedes, MD
Dr. Belen Nunez Cespedes, MD is a Nephrology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1780081059.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Belen Nunez Cespedes, MD has received a total of $1,135 in payments from pharmaceutical and medical device companies, with $183.33 received in 2024. These payments were reported across 17 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($676.18).
As a Medicare-enrolled provider, Nunez Cespedes has provided services to 1,612 Medicare beneficiaries, totaling 3,791 services with total Medicare billing of $267,193. Data is available for 3 years (2020–2022), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Nashville, TN
- Active Since 12/02/2014
- Last Updated 01/15/2026
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1780081059
Products in Payments
- AURYXIA (Drug) $145.64
- Auryxia (Drug) $141.74
- Veltassa (Drug) $122.02
- JYNARQUE (Drug) $118.34
- FARXIGA (Drug) $104.33
- ACTHAR (Biological) $79.00
- GAZYVA (Biological) $12.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Nashville
Dr. Jamie Dwyer, M.d, M.D
Nephrology — Payments: $549,974
Nephrology $549,974
Talat Ikizler, Md, MD
Nephrology — Payments: $240,153
Nephrology $240,153
Julia Lewis, Md, MD
Nephrology — Payments: $126,571
Nephrology $126,571
Dr. Volker Haase, M.d, M.D
Nephrology — Payments: $125,972
Nephrology $125,972
Alfred George, Md, MD
Nephrology — Payments: $51,836
Nephrology $51,836
Dr. Thomas Golper, Md, MD
Nephrology — Payments: $33,757
Nephrology $33,757